| S3809 |
Imperatorin
|
Imperatorin (Ammidin, Marmelosin, Pentosalen, 8-Isoamylenoxypsoralen), a naturally occurring psoralen-type furanocoumarin, is a potent myorelaxant agent and acts as a calcium antagonist on vascular smooth muscle.
|
-
Pharmaceuticals, 2023, 1595
-
Pharmaceuticals (Basel), 2023, 10.3390/ph16111595
-
Life, 2023, 1112
|
|
| E4980 |
Verapamil
|
Verapamil(Iproveratril,Dilacoran), is a phenylalkylamine derivative which is an antagonist of calcium influx and also an inhibitor P-gp and CYP3A4. It exhibits potency in treatment for angina, cardiac arrhythmias, cardiomyopathies and hypertension.
|
-
Nat Commun, 2025, 16(1):8069
-
J Am Heart Assoc, 2025, 14(1):e037400
-
Pharmaceuticals (Basel), 2025, 18(2)181
|
|
| E7160 |
Diltiazem
|
Diltiazem (Dilzen, CRD-401) is a benzothiazepine, an antagonist of Ca2+ channel inhibiting L-type Ca²⁺ currents via CaV1.2 channels in cardiac and vascular smooth muscle. It can be used in research of cardiac arrhythmia, hypertension, and angina pectoris.
|
-
Clin Exp Hypertens, 2025, 47(1):2515924
-
Biochem Biophys Res Commun, 2025, 786:152756
-
Function, 2023, zqad047
|
|
| S4931 |
Propiverine hydrochloride
|
Propiverine is an anticholinergic drug used for the treatment of overactive bladder and urinary incontinence. Propiverine is a muscarinic receptor antagonist possessing additional properties, i.e., block of L-type Ca2+ channels.
|
|
|
| S0870 |
Barnidipine
|
Barnidipine (Libradin, Mepirodipine, Vasexten, YM-09730-5, Cyress, Hypoca, Oldeca) is an antihypertensive drug that belongs to the dihydropyridine (DHP) group of calcium antagonist (CaA) with Ki of 0.21 nM for [3H]nitrendipine binding sites.
|
|
|
| E4919 |
Barnidipine hydrochloride
|
Barnidipine hydrochloride(Mepirodipine hydrochloride; YM-09730-5) is an antagonist of L-type calcium (CaA). It displays a high affinity for [3H] initrendipine binding sites with a Ki value of 0.21 nmol/l. This compound also acts as an antihypertensive agent.
|
|
|
| E1705 |
Mibefradil dihydrochloride
|
Mibefradil dihydrochloride (Ro 40-5967 dihydrochloride) is a nondihydropyridine antagonist of Ca++ channel, it reversibly inhibits the T-type and L-type currents with IC50 values of 2.7 μM and 18.6 μM, respectively. It increases coronary blood flow during ischemia and decreases smooth muscle proliferation after vascular injury, making it useful for congestive heart failure research.
|
|
|
| E0945 |
BIA
|
BIA (TMBIM6 antagonist BIA), a potential TMBIM6 antagonist, is an inhibitor of the interaction between TMBIM6 (Transmembrane B cell lymphoma 2-associated X protein (BAX) inhibitor motif-containing 6) and mTORC2, which ultimately blocks AKT activation and cancer progression.
|
|
|
| E0777 |
Z944
|
Z944 is a highly selective antagonist for T-type calcium channel with IC50s of 50, 160, 110 nM for hCaV3.1, hCaV3.2, and hCaV3.3.
|
|
|
| S2436 |
Pranidipine
|
Pranidipine (Acalas, OPC 13340) is a new 1,4-dihydropyridine calcium channel blocker. This compound can enhance cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
|
|
|
| E1410 |
Fluspirilene
|
Fluspirilene (R 6218; Redeptin) is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM in cell-free assays. This compound is a long-acting injectable depot antipsychotic agent used for schizophrenia.
|
|
|
| S5861 |
Lercanidipine
|
Lercanidipine is a vasoselective dihydropyridine calcium antagonist used for the treatment of essential hypertension.
|
|
|
| E7819 |
TTA-A2
|
TTA-A2 is a potent and selective antagonist of T-type calcium channel with an IC50 of 9.4 nM, and reduced PXR activation, promoting slow-wave sleep in mice. It shows strong efficacy in rodent models of epilepsy and sleep, making it a valuable preclinical tool for the research of a variety of human neurological diseases.
|
|
|